Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 538053, 10 pages
http://dx.doi.org/10.1155/2014/538053
Research Article

Gender Specific Association of RAS Gene Polymorphism with Essential Hypertension: A Case-Control Study

1Department of Bioinformatics, Alagappa University, Karaikudi, Tamil Nadu 630 004, India
2Genomics and Molecular Medicine Unit, CSIR-Institute of Genomics and Integrative Biology, Mall Road, New Delhi 110007, India

Received 23 February 2014; Accepted 24 March 2014; Published 17 April 2014

Academic Editor: James Stockand

Copyright © 2014 Kh. Dhanachandra Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Baima, M. Nicolaou, F. Schwartz et al., “Evidence for linkage between essential hypertension and a putative locus on human chromosome 17,” Hypertension, vol. 34, no. 1, pp. 4–7, 1999. View at Google Scholar · View at Scopus
  2. R. P. Lifton, A. G. Gharavi, and D. S. Geller, “Molecular mechanisms of human hypertension,” Cell, vol. 104, no. 4, pp. 545–556, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Škarić-Jurić, “Path analysis of familial resemblance in blood pressure in Middle Dalmatia, Croatia,” Collegium Antropologicum, vol. 27, no. 1, pp. 229–237, 2003. View at Google Scholar · View at Scopus
  4. X. Jeunemaitre, F. Soubrier, Y. V. Kotelevtsev et al., “Molecular basis of human hypertension: role of angiotensinogen,” Cell, vol. 71, no. 1, pp. 169–180, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. O'Donnell, K. Lindpaintner, M. G. Larson et al., “Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study,” Circulation, vol. 97, no. 18, pp. 1763–1772, 1998. View at Google Scholar · View at Scopus
  6. J. P. Forman, N. D. Fisher, M. R. Pollak et al., “Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors,” Journal of Clinical Hypertension, vol. 10, no. 6, pp. 459–466, 2008. View at Google Scholar
  7. A. Tsezou, G. Karayannis, E. Giannatou, V. Papanikolaou, and F. Triposkiadis, “Association of renin-angiotensin system and natriuretic peptide receptor A gene polymorphisms with hypertension in a Hellenic population,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 9, no. 4, pp. 202–207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Fornage, S. T. Turner, C. F. Sing, and E. Boerwinkle, “Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota,” Human Genetics, vol. 96, no. 3, pp. 295–300, 1995. View at Google Scholar · View at Scopus
  9. B. J. Morris, R. Y. L. Zee, and A. P. Schrader, “Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals,” Journal of Clinical Investigation, vol. 94, no. 3, pp. 1085–1089, 1994. View at Google Scholar · View at Scopus
  10. L. A. Hindorff, S. R. Heckbert, R. Tracy et al., “Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events,” The American Journal of Hypertension, vol. 15, no. 12, pp. 1050–1056, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. L. J. Bloem, T. M. Foroud, W. T. Ambrosius, M. P. Hanna, D. A. Tewksbury, and J. H. Pratt, “Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites,” Hypertension, vol. 29, no. 5, pp. 1078–1082, 1997. View at Google Scholar · View at Scopus
  12. X. Wu, A. Luke, M. Rieder et al., “An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population,” Journal of Hypertension, vol. 21, no. 10, pp. 1847–1852, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. V. U. Mohana, N. Swapna, R. S. Surender, S. Vishnupriya, and T. Padma, “Gender-related association of AGT gene variants (M235T and T174M) with essential hypertension: a case-control study,” Clinical and Experimental Hypertension, vol. 34, no. 1, pp. 38–44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Rudnichi, M. E. Safar, M. Lajemi, and A. Benetos, “Gene polymorphisms of the renin-angiotensin system and age-related changes in systolic and diastolic blood pressure in subjects with hypertension,” The American Journal of Hypertension, vol. 17, no. 4, pp. 321–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L.-D. Ji, L.-N. Zhang, P. Shen et al., “Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a meta-analysis,” Journal of Hypertension, vol. 28, no. 3, pp. 419–428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J.-L. Cheng, A.-L. Wang, and J. Wan, “Association between the M235T polymorphism of the AGT gene and cytokines in patients with hypertension,” Experimental and Therapeutic Medicine, vol. 3, no. 3, pp. 509–512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. E. Bernstein, H. D. Xiao, J. W. Adams et al., “Establishing the role of angiotensin-converting enzyme in renal function and blood pressure control through the analysis of genetically modified mice,” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. 583–591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J.-G. Wang and J. A. Staessen, “Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease,” European Journal of Pharmacology, vol. 410, no. 2-3, pp. 289–302, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Sakuma, R. D. C. Hirata, and M. H. Hirata, “Five polymorphisms in gene candidates for cardiovascular disease in Afro-Brazilian individuals,” Journal of Clinical Laboratory Analysis, vol. 18, no. 6, pp. 309–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Higaki, S. Baba, T. Katsuya et al., “Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita study,” Circulation, vol. 101, no. 17, pp. 2060–2065, 2000. View at Google Scholar · View at Scopus
  21. M. M. Zaman, N. Yoshiike, C. Date et al., “Angiotensin converting enzyme genetic polymorphism is not associated with hypertension in a cross-sectional sample of a Japanese population: the shibata study,” Journal of Hypertension, vol. 19, no. 1, pp. 47–53, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Li, “Angiotensin-converting enzyme gene insertion/deletion polymorphism and essential hypertension in the Chinese population: a meta-analysis including 21,058 participants,” Internal Medicine Journal, vol. 42, no. 4, pp. 439–444, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Qu, Y. Lu, and S. Lin, “Meta-analysis on the association of ACE/ID polymorphism and essential hypertension in Chinese population,” Zhonghua yu fang yi xue za zhi, vol. 35, no. 6, pp. 408–411, 2001. View at Google Scholar · View at Scopus
  24. W. Niu, Y. Qi, P. Gao, and D. Zhu, “Association between angiotensin converting enzyme G2350A polymorphism and hypertension risk: a meta-analysis,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 12, no. 1, pp. 8–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Kim and H. Iwao, “Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases,” Pharmacological Reviews, vol. 52, no. 1, pp. 11–34, 2000. View at Google Scholar · View at Scopus
  26. J. R. Ingelfinger, “Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 18, no. 1, pp. 79–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Bonnardeaux, E. Davies, X. Jeunemaitre et al., “Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension,” Hypertension, vol. 24, no. 1, pp. 63–69, 1994. View at Google Scholar · View at Scopus
  28. D. S. Shahin, Y. M. Irshaid, and A. A. Saleh, “The A(1166)C26 polymorphism of the AGTR1 gene is associated with an early onset of hypertension and high waist circumference in Jordanian males attending the Jordan University Hospital,” Clinical and Experimental Hypertension. In press.
  29. J.-L. Wang, L. Xu, P.-P. Hao, F. Xu, Y.-G. Chen, and Y. Zhang, “Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysis,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 11, no. 2, pp. 127–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Sugimoto, T. Katsuya, T. Ohkubo et al., “Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama study,” Hypertension Research, vol. 27, no. 8, pp. 551–556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Liu, C. Zhuoma, G. Shan et al., “A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations,” Hypertension Research, vol. 25, no. 4, pp. 515–521, 2002. View at Google Scholar · View at Scopus
  32. M. L. S. Cuddy, “Treatment of hypertension: guidelines from JNC 7 (the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure 1),” The Journal of Practical Nursing, vol. 55, no. 4, pp. 17–23, 2005. View at Google Scholar · View at Scopus
  33. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, Article ID 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Purcell, B. Neale, K. Todd-Brown et al., “PLINK: a tool set for whole-genome association and population-based linkage analyses,” The American Journal of Human Genetics, vol. 81, no. 3, pp. 559–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. W. D. Dupont and W. D. Plummer Jr., “Power and sample size calculations for studies involving linear regression,” Controlled Clinical Trials, vol. 19, no. 6, pp. 589–601, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. M. D. Ritchie, L. W. Hahn, N. Roodi et al., “Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer,” The American Journal of Human Genetics, vol. 69, no. 1, pp. 138–147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Yeoun Lee, Y. Chung, R. C. Elston, Y. Kim, and T. Park, “Log-linear model-based multifactor dimensionality reduction method to detect gene-gene interactions,” Bioinformatics, vol. 23, no. 19, pp. 2589–2595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J. H. Moore, J. C. Gilbert, C.-T. Tsai et al., “A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility,” Journal of Theoretical Biology, vol. 241, no. 2, pp. 252–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. N. E. Morton and A. Collins, “Tests and estimates of allelic association in complex inheritance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 19, pp. 11389–11393, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Ramachandran, P. Ismail, J. Stanslas, and N. Shamsudin, “Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects,” Cardiovascular Diabetology, vol. 8, article 11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Devi, V. Lakshmi, K. Padhy et al., “Association of ACE, AGT and AGTR1 gene polymorphisms with severity of coronary artery disease,” Journal of Dental and Medical Sciences, vol. 2, pp. 11–18, 2012. View at Google Scholar
  42. T. F. Ashavaid, K. K. Shalia, K. G. Nair et al., “ACE and AGTR1 gene polymorphisms and hypertension in Indian population,” Journal of Clinical Laboratory Analysis, vol. 14, no. 5, pp. 230–237, 2000. View at Google Scholar
  43. A. K. Islam and A. A. Majumder, “Hypertension in Bangladesh: a review,” Indian Heart Journal, vol. 64, no. 3, pp. 319–323, 2012. View at Google Scholar
  44. Badaruddoza, A. J. S. Bhanwer, R. Sawhney, N. K. Randhawa, K. Matharoo, and B. Barna, “A study of angiotensin converting enzyme (ACE) gene polymorphism in essential hypertension among a business community in Punjab,” International Journal of Human Genetics, vol. 9, no. 3-4, pp. 231–234, 2009. View at Google Scholar
  45. M. Das, S. Pal, and A. Ghosh, “Angiotensin converting enzyme gene polymorphism (Insertion/Deletion) and hypertension in adult Asian Indians: a population-based study from Calcutta, India,” Human Biology, vol. 80, no. 3, pp. 303–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Srivastava, S. Chandra, J. Bhatia et al., “Association of angiotensinogen (M235T) gene polymorphism with blood pressure lowering response to angiotensin converting enzyme inhibitor (Enalapril),” Journal of Pharmacy and Pharmaceutical Sciences, vol. 15, no. 3, pp. 399–406, 2012. View at Google Scholar
  47. B. Charita, G. Padma, P. Sushma et al., “Estimation of risk and interaction of single nucleotide polymorphisms at angiotensinogen locus causing susceptibility to essential hypertension: a case control study,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 13, no. 4, pp. 461–471, 2012. View at Google Scholar
  48. M. G. Chand, J. Srinath, R. S. Rao, B. V. K. S. Lakkakula, S. Kumar, and V. R. Rao, “Association between the M268T polymorphism in the angiotensinogen gene and essential hypertension in a South Indian population,” Biochemical Genetics, vol. 49, no. 7-8, pp. 474–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. J.-B. Marteau, M. Zaiou, G. Siest, and S. Visvikis-Siest, “Genetic determinants of blood pressure regulation,” Journal of Hypertension, vol. 23, no. 12, pp. 2127–2143, 2005. View at Google Scholar · View at Scopus
  50. M. R. Weir and V. J. Dzau, “The renin-angiotensin-aldosterone system: a specific target for hypertension management,” The American Journal of Hypertension, vol. 12, no. 12, pp. 205S–213S, 1999. View at Google Scholar · View at Scopus
  51. M. Karthikeyan, R. Rose, V. Shridevi et al., “Core promoter variants (A-20C, T-18C and G-6A) of the angiotensinogen (AGT) gene are not significantly associated with hypertension in patients of Tamilnadu, India,” International Journal of Human Genetics, vol. 9, no. 1, pp. 13–19, 2009. View at Google Scholar · View at Scopus
  52. A. D. Hingorani, P. Sharma, H. Jia et al., “Blood pressure and the M235T polymorphism of the angiotensinogen gene,” Hypertension, vol. 28, pp. 907–911, 1996. View at Google Scholar
  53. J. R. Ortlepp, H. P. Vosberg, S. Reith et al., “Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene,” Heart, vol. 87, no. 3, pp. 270–275, 2002. View at Google Scholar · View at Scopus
  54. M. Caulfield, P. Lavender, J. Newell-Price et al., “Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans,” Journal of Clinical Investigation, vol. 96, no. 2, pp. 687–692, 1995. View at Google Scholar · View at Scopus
  55. C. Rotimi, L. Morrison, R. Cooper et al., “Angiotensinogen gene in human hypertension: lack of an association of the 235T allele among African Americans,” Hypertension, vol. 24, no. 5, pp. 591–594, 1994. View at Google Scholar · View at Scopus
  56. D. Davis, N. Liyou, D. Lockwood, and A. Johnson, “Angiotensinogen genotype, plasma protein and mRNA concentration in isolated systolic hypertension,” Clinical Genetics, vol. 61, no. 5, pp. 363–368, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. Y.-J. Fang, H.-B. Deng, G. N. Thomas et al., “Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese,” Journal of Hypertension, vol. 28, no. 6, pp. 1203–1209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. 1000 Genomes Project Consortium, G. R. Abecasis, A. Auton et al., “An integrated map of genetic variation from 1,092 human genomes,” Nature, vol. 491, no. 7422, pp. 56–65, 2012. View at Google Scholar
  59. M. Karthikeyan, V. Shridevi, R. Rose et al., “Angiotensin gene polymorphisms (T174M and M235T) are significantly associated with the hypertensive patients of Tamil Nadu, South India,” International Journal of Human Genetics, vol. 13, no. 4, pp. 201–207, 2013. View at Google Scholar
  60. P. Ramu, G. Umamaheswaran, D. G. Shewade et al., “Candidate gene polymorphisms of renin angiotensin system and essential hypertension in a South Indian Tamilian population,” International Journal of Human Genetics, vol. 11, no. 1, pp. 31–40, 2011. View at Google Scholar · View at Scopus
  61. P. P. Kumar Manohar Rao, A. Munshi, R. Mullapudi et al., “The M235T polymorphism of the angiotensinogen gene in South Indian patients of hypertrophic cardiomyopathy,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 12, no. 3, pp. 238–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Prasad and B. K. Thelma, “Normative genetic profiles of RAAS pathway gene polymorphisms in North Indian and South Indian populations,” Human Biology, vol. 79, no. 2, pp. 241–254, 2007. View at Google Scholar · View at Scopus
  63. A. A. Sethi, B. G. Nordestgaard, and A. Tybæeg-Hansen, “Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 7, pp. 1269–1275, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. M. B. S. Freire, L. Ji, T. Onuma, T. Orban, J. H. Warram, and A. S. Krolewski, “Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM,” Hypertension, vol. 31, no. 4, pp. 896–899, 1998. View at Google Scholar · View at Scopus
  65. A. H. Jan Danser, F. H. M. Derkx, M. A. D. H. Schalekamp, H.-W. Hense, G. A. J. Riegger, and H. Schunkert, “Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans,” Journal of Hypertension, vol. 16, no. 6, pp. 853–862, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Schunkert, A. H. Jan Danser, H.-W. Hense, F. H. M. Derkx, S. Kürzinger, and G. A. J. Riegger, “Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women,” Circulation, vol. 95, no. 1, pp. 39–45, 1997. View at Google Scholar · View at Scopus
  67. C.-C. Hsu, M. S. Bray, W. H. L. Kao, J. S. Pankow, E. Boerwinkle, and J. Coresh, “Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. 504–512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Clauser, I. Gaillard, L. Wei, and P. Corvol, “Regulation of angiotensinogen gene,” The American Journal of Hypertension, vol. 2, no. 5, pp. 403–410, 1989. View at Google Scholar · View at Scopus
  69. M. Feldmer, M. Kaling, S. Takahashi, J. J. Mullins, and D. Ganten, “Glucocorticoid- and estrogen-responsive elements in the 5′-flanking region of the rat angiotensinogen gene,” Journal of Hypertension, vol. 9, no. 11, pp. 1005–1012, 1991. View at Google Scholar · View at Scopus
  70. J. A. Staessen, J. G. Wang, G. Ginocchio et al., “The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk,” Journal of Hypertension, vol. 15, no. 12, pp. 1579–1592, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Schunkert, “Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease,” Journal of Molecular Medicine, vol. 75, no. 11-12, pp. 867–875, 1997. View at Google Scholar · View at Scopus
  72. M. Morshed, H. Khan, and S. Akhteruzzaman, “Association between angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals of the Bangladeshi population,” Journal of Biochemistry and Molecular Biology, vol. 35, no. 3, pp. 251–254, 2002. View at Google Scholar · View at Scopus
  73. J.-H. Yoo, “Deletion polymorphism in the gene for angiotensin-converting enzyme is associated with essential hypertension in men born during the Pacific War,” Mechanisms of Ageing and Development, vol. 126, no. 8, pp. 899–905, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Higaki, S. Baba, T. Katsuya et al., “Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita study,” Circulation, vol. 101, no. 17, pp. 2060–2065, 2000. View at Google Scholar · View at Scopus
  75. K. Nakai, C. Itoh, Y. Miura et al., “Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese,” Circulation, vol. 90, no. 5, pp. 2199–2202, 1994. View at Google Scholar · View at Scopus
  76. L. Tiret, B. Rigat, S. Visvikis et al., “Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels,” The American Journal of Human Genetics, vol. 51, no. 1, pp. 197–205, 1992. View at Google Scholar · View at Scopus
  77. R. Y. L. Zee, Y.-K. Lou, L. R. Griffiths, and B. J. Morris, “Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension,” Biochemical and Biophysical Research Communications, vol. 184, no. 1, pp. 9–15, 1992. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Azizi, M. Hallouin, X. Jeunemaitre, T. T. Guyene, and J. Ménard, “Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 11, pp. 4331–4337, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. L. M. Hilliard, A. K. Sampson, R. D. Brown et al., “The “his and hers” of the renin-angiotensin system,” Current Hypertension Reports, vol. 15, no. 1, pp. 71–79, 2013. View at Google Scholar
  80. D. Grady, S. M. Rubin, D. B. Petitti et al., “Hormone therapy to prevent disease and prolong life in postmenopausal women,” Annals of Internal Medicine, vol. 117, no. 12, pp. 1016–1037, 1992. View at Google Scholar · View at Scopus
  81. A. Bobik, “Striatin-dependent membrane estrogen receptor signaling and vasoprotection by estrogens,” Circulation, vol. 126, no. 16, pp. 1941–1943, 2012. View at Google Scholar